SCHEMBL219820

SCHEMBL219820

CC(O)C1CNCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL22122714 0.98 GBA1 (0.33)
SCHEMBL11438137 0.82
SCHEMBL9784324 0.82 MAPT (0.32)
SCHEMBL2911557 0.80
SCHEMBL9583103 0.80
SCHEMBL4042067 0.80
SCHEMBL19017774 0.80
SCHEMBL64698 0.80
SCHEMBL6805621 0.79
SCHEMBL12961391 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1112302-B1 CATAPHORETIC ELECTRODEPOSITION OF POLYETHERIMIDE GEN ELECTRIC (US) 2003-09-17 EP claimed
US-10800771-B2 Process for the preparation of dasatinib polymorph NATCO PHARMA LIMITED (IN) 2020-10-13 US disclosed
US-20190292177-A1 AN IMPROVED PROCESS FOR THE PREPARATION OF DASATINIB POLYMORPH NATCO PHARMA LIMITED (IN) 2019-09-26 US disclosed
US-9714247-B2 Multiple kinase pathway inhibitors TOLERO PHARMACEUTICALS, INC. (US) 2017-07-25 US disclosed
US-20170107215-A1 MULTIPLE KINASE PATHWAY INHIBITORS SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2017-04-20 US disclosed
US-9518240-B2 Process for the treatment of liquefied hydrocarbons using 3-(piperazine-1-YL)propane-1,2-diol compounds DOW GLOBAL TECHNOLOGIES LLC (US) 2016-12-13 US disclosed
US-9493454-B2 Multiple kinase pathway inhibitors TOLERO PHARMACEUTICALS, INC. (US) 2016-11-15 US disclosed
EP-2861699-B1 PROCESS FOR THE TREATMENT OF LIQUEFIED HYDROCARBONS USING 3-(PIPERAZINE-1-YL) PROPANE-1,2-DIOL COMPOUNDS DOW GLOBAL TECHNOLOGIES LLC (US) 2016-10-19 EP disclosed
CN-102847414-B The carbon dioxide recovery system, in accordance of waste gas and method 现代自动车株式会社 2016-08-17 CN disclosed
CN-103080269-B Photochromic composition TOKUYAMA CORP. (JP) 2015-12-16 CN disclosed
US-20040024057-A1 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use related applications NITROMED, INC. 2004-02-05 US disclosed
EP-0625997-B2 AMINOCARBONATE COMPOUNDS AND THEIR USE AS CATALYSTS AIR PROD & CHEM (US) 2000-12-27 EP disclosed
US-5686643-A FOR PRODUCING POLYURETHANES OR POLYUREAS AIR PRODUCTS AND CHEMICALS, INC. (US) 1997-11-11 US disclosed
EP-0625997-B1 AMINOCARBONATE COMPOUNDS AND THEIR USE AS CATALYSTS AIR PROD & CHEM (US) 1997-05-07 EP disclosed
EP-0625997-A1 DIAMINOCARBONATE COMPOUNDS AND THEIR USE AS CATALYSTS. RWE DEA AG (DE) 1994-11-30 EP disclosed
WO-1993016124-A1 DIAMINOCARBONATE COMPOUNDS AND THEIR USE AS CATALYSTS RWE-DEA Aktiengesellschaft für Mineraloel und Chemie (DE) 1993-08-19 WO disclosed
US-4766125-A N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia JANSSEN PHARMACEUTICA N.V. (BE) 1988-08-23 US disclosed
EP-0068544-B1 NOVEL N-ARYL-PIPERAZINEALKANAMIDES JANSSEN PHARMACEUTICA N.V. (BE) 1987-06-03 EP disclosed
US-4617418-A REACTING AMMONIA, A POLYALKYLENEPOLYAMINE AND AN AMINOALKANOL USING A SOLID ACID CATALYST BED AIR PRODUCTS AND CHEMICALS, INC. (US) 1986-10-14 US disclosed
EP-0068544-A2 Novel N-aryl-piperazinealkanamides JANSSEN PHARMACEUTICA N.V. (BE) 1983-01-05 EP disclosed